JPH10231292A5 - - Google Patents
Info
- Publication number
- JPH10231292A5 JPH10231292A5 JP1997278908A JP27890897A JPH10231292A5 JP H10231292 A5 JPH10231292 A5 JP H10231292A5 JP 1997278908 A JP1997278908 A JP 1997278908A JP 27890897 A JP27890897 A JP 27890897A JP H10231292 A5 JPH10231292 A5 JP H10231292A5
- Authority
- JP
- Japan
- Prior art keywords
- phenoxy
- piperidinyl
- hydroxyphenyl
- hydroxynaphthalene
- ethylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2844196P | 1996-10-10 | 1996-10-10 | |
| US60/028441 | 1996-10-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10231292A JPH10231292A (ja) | 1998-09-02 |
| JPH10231292A5 true JPH10231292A5 (enExample) | 2005-06-16 |
Family
ID=21843469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9278908A Withdrawn JPH10231292A (ja) | 1996-10-10 | 1997-10-13 | ２−アリール−３−アミノアリールオキシナフチル化合物、中間体、組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0835868B1 (enExample) |
| JP (1) | JPH10231292A (enExample) |
| AT (1) | ATE204868T1 (enExample) |
| CA (1) | CA2217810A1 (enExample) |
| DE (1) | DE69706386T2 (enExample) |
| DK (1) | DK0835868T3 (enExample) |
| ES (1) | ES2161417T3 (enExample) |
| PT (1) | PT835868E (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI0826679T1 (en) * | 1996-08-29 | 2002-04-30 | Eli Lilly And Company | Naphthyl compounds and compositions |
| ID19392A (id) | 1996-08-29 | 1998-07-09 | Lilly Co Eli | Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan |
| CA2287244A1 (en) * | 1997-04-25 | 1998-11-05 | Henry Uhlman Bryant | Indene compounds having activity as serms |
| WO2000041699A1 (en) * | 1999-01-18 | 2000-07-20 | Novo Nordisk A/S | Use of estrogens and delta-gonadien-21-ol-3,20-diones |
| KR20020026561A (ko) * | 1999-08-03 | 2002-04-10 | 존 헤덴스트룀 | 압축 가능한 컨테이너 및 컨테이너 제조 방법과, 액체수용 컨테이너와, 액체 분출 방법 및 장치와, 키트 또는조합체 |
| AU7896100A (en) * | 1999-10-14 | 2001-04-23 | Endorecherche Inc. | Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance |
| CZ2004118A3 (cs) | 2001-07-31 | 2004-09-15 | Pfizer Products Inc. | Farmaceutický prostředek, kit a způsoby zahrnující kombinaci činidla estrogenový agonist/antagonist, estrogenu a progestinu |
| NZ537138A (en) | 2002-07-22 | 2007-11-30 | Lilly Co Eli | Selective estrogen receptor modulators containing a phenylsulfonyl group |
| PL377494A1 (pl) * | 2003-02-25 | 2006-02-06 | Eli Lilly And Company | Krystaliczny, niesolwatowany chlorowodorek 1-(4-(2-pipe-rydynyloetoksy) fenoksy)-2-(4-metanosulfonylofenylo)-6- hydroksynaftalenu |
| CN1910167B (zh) * | 2004-01-22 | 2011-08-10 | 伊莱利利公司 | 用于治疗血管舒缩症状的选择性雌激素受体调节剂 |
| ATE476428T1 (de) * | 2004-01-22 | 2010-08-15 | Lilly Co Eli | Selektive modulatoren des östrogenrezeptors zur behandlung von vasomotorischen symptomen |
| RU2352555C2 (ru) * | 2004-06-22 | 2009-04-20 | Смитклайн Бичем Корпорейшн | ХИМИЧЕСКИЕ СОЕДИНЕНИЯ, СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИХ ПРИМЕНЕНИЕ (ВАРИАНТЫ) И СПОСОБ СВЯЗЫВАНИЯ ERα И ERβ-ЭСТРОГЕНОВЫХ РЕЦЕПТОРОВ |
| FR2913017A1 (fr) * | 2007-02-23 | 2008-08-29 | Cerep Sa | Derives de piperidine et piperazine comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire |
| CN114133336B (zh) * | 2020-09-03 | 2024-04-02 | 沈阳药科大学 | 4-甲氧基萘取代的苯胺类化合物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
| US5811421A (en) * | 1995-07-31 | 1998-09-22 | Eli Lilly And Company | Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
-
1997
- 1997-10-07 CA CA002217810A patent/CA2217810A1/en not_active Abandoned
- 1997-10-09 AT AT97308005T patent/ATE204868T1/de not_active IP Right Cessation
- 1997-10-09 DE DE69706386T patent/DE69706386T2/de not_active Expired - Fee Related
- 1997-10-09 DK DK97308005T patent/DK0835868T3/da active
- 1997-10-09 PT PT97308005T patent/PT835868E/pt unknown
- 1997-10-09 EP EP97308005A patent/EP0835868B1/en not_active Expired - Lifetime
- 1997-10-09 ES ES97308005T patent/ES2161417T3/es not_active Expired - Lifetime
- 1997-10-13 JP JP9278908A patent/JPH10231292A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10231292A5 (enExample) | ||
| FI117373B (fi) | Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti | |
| US4929605A (en) | Pharmaceutical composition for piperidinoalkanol derivatives | |
| CN1125396A (zh) | 阿司咪唑和假麻黄碱的缓释薄膜包衣片 | |
| CA2253453A1 (en) | Alkylaminobenzothiazole and -benzoxazole derivatives | |
| US4159335A (en) | Substituted anilino-2-thiazolines | |
| TW467913B (en) | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt and its preparation | |
| US6514529B2 (en) | Oxazolidinone tablet formulation | |
| US4379155A (en) | 3,5-Disubstituted-1H-1,2,4-triazole derivatives | |
| EP0310999B1 (en) | Pharmaceutical composition for piperidinoalkanol derivatives | |
| EP1265608B1 (en) | Oxazolidinone tablet formulation | |
| SK15472001A3 (sk) | Použitie saredutantu a jeho farmaceuticky prijateľných solí na prípravu liečiva použiteľného na liečenie alebo prevenciu porúch nálady, porúch adaptácie alebo stavov úzkosti a depresie | |
| CA2576067A1 (en) | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof | |
| US20080234323A1 (en) | Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride | |
| AU2022407440A1 (en) | Solid state forms of an fgfr inhibitor | |
| JPH1095778A5 (enExample) | ||
| CA2077122A1 (en) | Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same | |
| AU2001243243A1 (en) | Oxazolidinone tablet formulation | |
| US3789125A (en) | Pharmaceutical compositions containing halo-substituted 2-amino-benzylamine-amides | |
| RU2001124835A (ru) | Новые производные морфолина, способ их получения и содержащие их фармацевтические композиции | |
| HUP0104514A2 (en) | The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence | |
| US4206217A (en) | 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds | |
| CY1499A (en) | Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist | |
| US3993778A (en) | Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use | |
| US2727896A (en) | Derivatives of pyrrole and process |